Global Gout Therapeutics Market Research Report 2023

Report ID: 1988968 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 NSAIDs
        1.2.3 Corticosteroids
        1.2.4 Colchicine
        1.2.5 Urate-Lowering Agents
    1.3 Market by Application
        1.3.1 Global Gout Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Acute Gout
        1.3.3 Chronic Gout
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gout Therapeutics Market Perspective (2017-2028)
    2.2 Gout Therapeutics Growth Trends by Region
        2.2.1 Gout Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gout Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Gout Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Gout Therapeutics Market Dynamics
        2.3.1 Gout Therapeutics Industry Trends
        2.3.2 Gout Therapeutics Market Drivers
        2.3.3 Gout Therapeutics Market Challenges
        2.3.4 Gout Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gout Therapeutics Players by Revenue
        3.1.1 Global Top Gout Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gout Therapeutics Revenue
    3.4 Global Gout Therapeutics Market Concentration Ratio
        3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2021
    3.5 Gout Therapeutics Key Players Head office and Area Served
    3.6 Key Players Gout Therapeutics Product Solution and Service
    3.7 Date of Enter into Gout Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gout Therapeutics Breakdown Data by Type
    4.1 Global Gout Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Gout Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gout Therapeutics Breakdown Data by Application
    5.1 Global Gout Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Gout Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gout Therapeutics Market Size (2017-2028)
    6.2 North America Gout Therapeutics Market Size by Country (2017-2022)
    6.3 North America Gout Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gout Therapeutics Market Size (2017-2028)
    7.2 Europe Gout Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Gout Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gout Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Gout Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gout Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gout Therapeutics Market Size (2017-2028)
    9.2 Latin America Gout Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Gout Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gout Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Gout Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gout Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Takeda Pharmaceutical Company
        11.1.1 Takeda Pharmaceutical Company Company Detail
        11.1.2 Takeda Pharmaceutical Company Business Overview
        11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction
        11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022)
        11.1.5 Takeda Pharmaceutical Company Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Gout Therapeutics Introduction
        11.2.4 Novartis Revenue in Gout Therapeutics Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Gout Therapeutics Introduction
        11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 GlaxoSmithKline
        11.4.1 GlaxoSmithKline Company Detail
        11.4.2 GlaxoSmithKline Business Overview
        11.4.3 GlaxoSmithKline Gout Therapeutics Introduction
        11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022)
        11.4.5 GlaxoSmithKline Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Gout Therapeutics Introduction
        11.5.4 Merck Revenue in Gout Therapeutics Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Regeneron Pharmaceuticals
        11.6.1 Regeneron Pharmaceuticals Company Detail
        11.6.2 Regeneron Pharmaceuticals Business Overview
        11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction
        11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022)
        11.6.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of NSAIDs
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Colchicine
    Table 5. Key Players of Urate-Lowering Agents
    Table 6. Global Gout Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gout Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Gout Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Gout Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Gout Therapeutics Market Share by Region (2023-2028)
    Table 12. Gout Therapeutics Market Trends
    Table 13. Gout Therapeutics Market Drivers
    Table 14. Gout Therapeutics Market Challenges
    Table 15. Gout Therapeutics Market Restraints
    Table 16. Global Gout Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Gout Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
    Table 19. Ranking of Global Top Gout Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Gout Therapeutics Product Solution and Service
    Table 23. Date of Enter into Gout Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Gout Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Gout Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Gout Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Gout Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Gout Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Takeda Pharmaceutical Company Company Detail
    Table 44. Takeda Pharmaceutical Company Business Overview
    Table 45. Takeda Pharmaceutical Company Gout Therapeutics Product
    Table 46. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Takeda Pharmaceutical Company Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Gout Therapeutics Product
    Table 51. Novartis Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. AstraZeneca Company Detail
    Table 54. AstraZeneca Business Overview
    Table 55. AstraZeneca Gout Therapeutics Product
    Table 56. AstraZeneca Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. AstraZeneca Recent Development
    Table 58. GlaxoSmithKline Company Detail
    Table 59. GlaxoSmithKline Business Overview
    Table 60. GlaxoSmithKline Gout Therapeutics Product
    Table 61. GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. GlaxoSmithKline Recent Development
    Table 63. Merck Company Detail
    Table 64. Merck Business Overview
    Table 65. Merck Gout Therapeutics Product
    Table 66. Merck Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Merck Recent Development
    Table 68. Regeneron Pharmaceuticals Company Detail
    Table 69. Regeneron Pharmaceuticals Business Overview
    Table 70. Regeneron Pharmaceuticals Gout Therapeutics Product
    Table 71. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Regeneron Pharmaceuticals Recent Development
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gout Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. NSAIDs Features
    Figure 3. Corticosteroids Features
    Figure 4. Colchicine Features
    Figure 5. Urate-Lowering Agents Features
    Figure 6. Global Gout Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Acute Gout Case Studies
    Figure 8. Chronic Gout Case Studies
    Figure 9. Gout Therapeutics Report Years Considered
    Figure 10. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gout Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gout Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Gout Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2021
    Figure 16. North America Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gout Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gout Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gout Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gout Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gout Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 46. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 49. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
Frequently Asked Questions
Gout Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gout Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gout Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

GPS Bike Computers

GPS Bike Computers market is segmented by players, region (country), by Type and by Application.  ... Read More